Alan Pollack
University of Miami
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alan Pollack as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:22 UTC. Open this list on ClinicalTrials.gov
- N/ANCT02997709 · Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy PatientsUniversity of Miami · recruiting · Prostate Cancer · principal investigator
- N/ANCT02307058 · Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated RadiotherapyUniversity of Miami · active not recruiting · Prostate Cancer · principal investigator
- N/ANCT01838265 · Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided ManagementUniversity of Miami · withdrawn · Prostate Cancer, Prostate Adenocarcinoma · principal investigator
- N/ANCT01794403 · Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate CancerUniversity of Miami · active not recruiting · Prostate Cancer · principal investigator
- N/ANCT01411319 · MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate CancerUniversity of Miami · completed · Prostate Cancer, Prostate Adenocarcinoma · principal investigator
- N/ANCT01411332 · Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT TrialUniversity of Miami · completed · Prostate Cancer, Prostate Adenocarcinoma · principal investigator
- Ph3NCT00567580 · Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate CancerRadiation Therapy Oncology Group · unknown · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Longitudinal Imaging and Liquid Biopsy Markers of Prostate Cancer Radiotherapy OutcomesR01CA294824 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · fiscal years 2025 to 2026 · $528,207 awarded in 2026Same name and institution; not confirmed by an ID
- Prostate Needle Biopsies: Impact of Preanalytical Procurement and Processing Variables on the Detection of Gene Expression Signatures of Prostate Cancer AggressivenessU01CA271400 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · fiscal years 2022 to 2026 · $351,131 awarded in 2026Same name and institution; not confirmed by an ID
- The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer DetectionR01CA272766 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · fiscal years 2023 to 2026 · $411,697 awarded in 2026Same name and institution; not confirmed by an ID
- UM Calabresi Clinical Oncology Research Career Development AwardK12CA226330 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · fiscal years 2020 to 2026 · $764,063 awarded in 2026Same name and institution; not confirmed by an ID
- MRI Imaging and Biomarkers for Early Detection of Aggressive Prostate CancerU01CA239141 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · fiscal years 2019 to 2023 · $557,666 awarded in 2023Same name and institution; not confirmed by an ID
- MRI Imaging and Genetic Signatures to Manage Prostate Cancer OverdiagnosisR01CA189295 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · fiscal years 2014 to 2018 · $560,366 awarded in 2018Same name and institution; not confirmed by an ID
- MRI-Guided Radiotherapy and Biomarkers for Prostate CancerR21CA153826 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · fiscal years 2010 to 2011 · $307,951 awarded in 2011Grant number is on one of their registry trials
- Biomarker Models of Prostate Cancer Outcome After RadiotherapyR21CA133632 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · fiscal years 2009 to 2010 · $198,806 awarded in 2010Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:22 UTC. The ranking covers the 200 most relevant of 77 PubMed records, and a shared surname and initials can bring in a namesake. All 77 on PubMed
- Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial.Int J Radiat Oncol Biol Phys · 20021,074 citationsRCR 28.9
- Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer.Int J Radiat Oncol Biol Phys · 20081,020 citationsRCR 27.5
- Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer.J Clin Oncol · 2000413 citationsRCR 11.3
- Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.J Clin Oncol · 2013388 citationsRCR 12.2
- Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial.Int J Radiat Oncol Biol Phys · 2000338 citationsRCR 10.3
- 264 citationsRCR 7.5
- 233 citationsRCR 17.6
- Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial.Int J Radiat Oncol Biol Phys · 2006200 citationsRCR 5.7
- Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?Int J Radiat Oncol Biol Phys · 2011190 citationsRCR 6.0
- Prostate target volume variations during a course of radiotherapy.Int J Radiat Oncol Biol Phys · 1998174 citationsRCR 7.4